Lenalidomide: Phase III started

Last quarter, Celgene began a Phase III (SWOG S0777) trial in 440 patients to evaluate oral Revlimid plus low-dose dexamethasone with or without Velcade bortezomib. Millennium Pharmaceuticals Inc., ...